Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 391512, 7 pages
http://dx.doi.org/10.1155/2014/391512
Research Article

Cytotoxic Effect of Icaritin and Its Mechanisms in Inducing Apoptosis in Human Burkitt Lymphoma Cell Line

1Division of Hematology, The First Affiliated Hospital, Lanzhou University, Lanzhou, Gansu 730000, China
2Division of Nephrology, The First Affiliated Hospital, Lanzhou University, Lanzhou, Gansu 730000, China
3Division of Hematology, The Second Xiang-Ya Hospital, Central South University, Changsha, Hunan 410011, China

Received 16 February 2014; Revised 13 April 2014; Accepted 14 April 2014; Published 7 May 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 Zi-Jian Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Sant, C. Allemani, C. Tereanu et al., “Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project,” Blood, vol. 116, no. 19, pp. 3724–3734, 2010. View at Google Scholar
  2. J. Tong, Q. Zhang, X. Huang et al., “Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells,” PLoS ONE, vol. 6, no. 3, Article ID e16781, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Huang, D. Zhu, and Y. Lou, “A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells,” European Journal of Pharmacology, vol. 564, no. 1–3, pp. 26–36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Guo, X. Zhang, J. Meng, and Z. Wang, “An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells,” European Journal of Pharmacology, vol. 658, no. 2-3, pp. 114–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Hong, Z. Zhang, W. Lv et al., “Icaritin synergistically enhances the radiosensitivity of 4T1 breast cancer cells,” PloS ONE, vol. 8, no. 8, Article ID e71347, 2013. View at Google Scholar
  6. J. He, Y. Wang, F. Duan, H. Jiang, M. Chen, and S. Tang, “Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor,” Planta Medica, vol. 76, no. 16, pp. 1834–1839, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Sun, W. Chen, L. Qu et al., “Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and Pglycoprotein expression,” Molecular Medicine Reports, vol. 8, no. 6, pp. 1883–1887, 2013. View at Google Scholar
  8. Q. Li, L. Huai, C. Zhang et al., “Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways,” International Journal of Hematology, vol. 97, no. 5, pp. 617–623, 2013. View at Google Scholar
  9. J. F. Zhu, Z. J. Li, G. S. Zhang et al., “Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3/AKT signalings,” PLoS ONE, vol. 6, no. 8, Article ID e23720, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Wu, H. Xu, P. F. Wong et al., “Icaritin attenuates cigarette smoke-mediated oxidative stress in human lung epithelial cells via activation of PI3K-AKT and Nrf2 signaling,” Food and Chemical Toxicology, vol. 64, no. 2, pp. 307–313, 2014. View at Google Scholar
  11. S. Li, S. J. Priceman, H. Xin et al., “Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma,” PloS ONE, vol. 8, no. 12, Article ID e81657, 2013. View at Google Scholar
  12. S. M. Aukema, R. Siebert, E. Schuuring et al., “Double-hit B-cell lymphomas,” Blood, vol. 117, no. 8, pp. 2319–2331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Klapproth and T. Wirth, “Advances in the understanding of MYC-induced lymphomagenesis,” British Journal of Haematology, vol. 149, no. 4, pp. 484–497, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Vermeulen, Z. N. Berneman, and D. R. van Bockstaele, “Cell cycle and apoptosis,” Cell Proliferation, vol. 36, no. 3, pp. 165–175, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. M. Abrams and M. A. White, “Coordination of cell death and the cell cycle: linking proliferation to death through private and communal couplers,” Current Opinion in Cell Biology, vol. 16, no. 6, pp. 634–638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. S. W. G. Tait and D. R. Green, “Mitochondria and cell death: outer membrane permeabilization and beyond,” Nature Reviews Molecular Cell Biology, vol. 11, no. 9, pp. 621–632, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Kurokawa and S. Kornbluth, “Caspases and kinases in a death grip,” Cell, vol. 138, no. 5, pp. 838–854, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. I. Gomez-Curet, R. S. Perkins, R. Bennett, K. L. Feidler, S. P. Dunn, and L. J. Krueger, “c-Myc inhibition negatively impacts lymphoma growth,” Journal of Pediatric Surgery, vol. 41, no. 1, pp. 207–211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. He and B. Fang, “Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells,” Acta Biochimica et Biophysica Sinica, vol. 41, no. 2, pp. 131–136, 2009. View at Publisher · View at Google Scholar · View at Scopus